Metabolic syndrome criteria: ready for clinical prime time or work in progress?

被引：10

作者：

Sattar, N

Forouhi, NG

机构：

[1] Univ Glasgow, Glasgow Royal Infirm, Div Cardiovasc & Med Sci, Sect Vasc Biochem, Glasgow G31 2ER, Lanark, Scotland

[2] MRC, Epidemiol Unit, Cambridge CB1 8RN, England

来源：

EUROPEAN HEART JOURNAL | 2005年 / 26卷 / 13期

关键词：

D O I：

10.1093/eurheartj/ehi296

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1249 / 1251

页数：3

共 14 条

[1] Effects of fosinopril and pravastatin on cardiovascular events in subjects with microalbuminuria [J].

Asselbergs, FW ;

Diercks, GFH ;

Hillege, HL ;

van Boven, AJ ;

Janssen, WMT ;

Voors, AA ;

de Zeeuw, D ;

de Jong, PE ;

van Veldhuisen, DJ ;

van Gilst, WH .

CIRCULATION, 2004, 110 (18) :2809-2816

[2] Inflammation, insulin resistance, and glucose intolerance in acute myocardial infarction patients without a previous diagnosis of diabetes mellitus [J].

Choi, KM ;

Lee, KW ;

Kim, SG ;

Kim, NH ;

Park, CG ;

Seo, HS ;

Oh, DJ ;

Choi, DS ;

Baik, SH .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (01) :175-180

[3] Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].

Cleeman, JI ;

Grundy, SM ;

Becker, D ;

Clark, LT ;

Cooper, RS ;

Denke, MA ;

Howard, WJ ;

Hunninghake, DB ;

Illingworth, DR ;

Luepker, RV ;

McBride, P ;

McKenney, JM ;

Pasternak, RC ;

Stone, NJ ;

Van Horn, L ;

Brewer, HB ;

Ernst, ND ;

Gordon, D ;

Levy, D ;

Rifkind, B ;

Rossouw, JE ;

Savage, P ;

Haffner, SM ;

Orloff, DG ;

Proschan, MA ;

Schwartz, JS ;

Sempos, CT ;

Shero, ST ;

Murray, EZ .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497

[4] Impact of statins in microalbuminuric subjects with the metabolic syndrome: a substudy of the PREVEND Intervention Trial [J].

Geluk, CA ;

Asselbergs, FW ;

Hillege, HL ;

Bakker, SJL ;

de Jong, PE ;

Zijlstra, F ;

van Gilst, WH .

EUROPEAN HEART JOURNAL, 2005, 26 (13) :1314-1320

[5] Prognostic implications of retinopathy and a high plasma von Willebrand factor concentration in type 2 diabetic subjects with microalbuminuria [J].

Jager, A ;

van Hinsbergh, VWM ;

Kostense, PJ ;

Emeis, JJ ;

Nijpels, G ;

Dekker, JM ;

Heine, RJ ;

Bouter, LM ;

Stehouwer, CDS .

NEPHROLOGY DIALYSIS TRANSPLANTATION, 2001, 16 (03) :529-536

[6] Metabolic syndrome - In search of a clinical role [J].

Meigs, JB .

DIABETES CARE, 2004, 27 (11) :2761-2763

[7] Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus:: a prospective study [J].

Norhammar, A ;

Tenerz, Å ;

Nilsson, G ;

Hamsten, A ;

Efendíc, S ;

Rydén, L ;

Malmberg, K .

LANCET, 2002, 359 (9324) :2140-2144

[8] Reduction of cardiovascular events by simvastatinin in nondiabetic coronary heart disease patients with and without the metabolic syndrome -: Subgroup analyses of the Scandinavian Simvastatin Survival Study (4S) [J].

Pyörälä, K ;

Ballantyne, CM ;

Gumbiner, B ;

Lee, MW ;

Shah, A ;

Davies, MJ ;

Mitchel, YB ;

Pedersen, TR ;

Kjekshus, J .

DIABETES CARE, 2004, 27 (07) :1735-1740

[9]

REAVEN GM, 2005, CLIN CHEM

[10] C-reactive protein levels and outcomes after statin therapy [J].

Ridker, PM ;

Cannon, CP ;

Morrow, D ;

Rifai, N ;

Rose, LM ;

McCabe, CH ;

Pfeffer, MA ;

Braunwald, E .

NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (01) :20-28

← 1 2 →